Search Results - "van der Boog, Paul"

Refine Results
  1. 1

    Medication non-adherence after kidney transplantation: A critical appraisal and systematic review by Gokoel, Sumit R.M, Gombert-Handoko, Kim B, Zwart, Tom C, van der Boog, Paul J.M, Moes, Dirk Jan A.R, de Fijter, Johan W

    “…SummaryMedication non-adherence is one of the most important causes for shortened graft survival subsequently leading to a reduction in kidney graft survival…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Mycophenolic Acid Exposure Determines Antibody Formation Following SARS‐CoV‐2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study by Meziyerh, Soufian, Bouwmans, Pim, Gelder, Teun, Helm, Danny, Messchendorp, Lianne, Boog, Paul J. M., Fijter, Johan W., Moes, Dirk Jan A. R., Vries, Aiko P. J.

    Published in Clinical pharmacology and therapeutics (01-07-2023)
    “…Despite (repeated) boosting, kidney transplant recipients (KTRs) may remain at increased risk of severe COVID‐19 since a substantial number of individuals…”
    Get full text
    Journal Article
  4. 4

    Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device by Zwart, Tom C., Gokoel, Sumit R.M., Boog, Paul J.M., Fijter, Johan W., Kweekel, Dina M., Swen, Jesse J., Guchelaar, Henk‐Jan, Moes, Dirk Jan A.R.

    Published in British journal of clinical pharmacology (01-12-2018)
    “…Aims Tacrolimus and mycophenolic acid dosing after renal transplantation is individualized through therapeutic drug monitoring (TDM). Home‐based dried blood…”
    Get full text
    Journal Article
  5. 5

    Development and evaluation of an eHealth self-management intervention for patients with chronic kidney disease in China: protocol for a mixed-method hybrid type 2 trial by Shen, Hongxia, van der Kleij, Rianne, van der Boog, Paul J M, Song, Xiaoyue, Wang, Wenjiao, Zhang, Tongtong, Li, Zhengyan, Lou, Xiaoping, Chavannes, Niels

    Published in BMC nephrology (19-11-2020)
    “…Chronic kidney disease (CKD) is a significant public health concern. In patients with CKD, interventions that support disease self-management have shown to…”
    Get full text
    Journal Article
  6. 6

    Electronic Health Self-Management Interventions for Patients With Chronic Kidney Disease: Systematic Review of Quantitative and Qualitative Evidence by Shen, Hongxia, van der Kleij, Rianne M J J, van der Boog, Paul J M, Chang, Xinwei, Chavannes, Niels H

    Published in Journal of medical Internet research (05-11-2019)
    “…Chronic kidney disease (CKD) poses a major challenge to public health. In CKD patients, adequate disease self-management has been shown to improve both…”
    Get full text
    Journal Article
  7. 7

    Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients by Kamp, Jasper, Zwart, Tom C, Meziyerh, Soufian, van der Boog, Paul J M, Nijgh, Esther E, van Duin, Koen, de Vries, Aiko P J, Moes, Dirk Jan A R

    Published in Pharmaceutics (21-12-2023)
    “…Meltdose tacrolimus (Envarsus ) has been marketed as a formulation achieving a more consistent tacrolimus exposure. Due to the narrow therapeutic window of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Outcomes after kidney transplantation, let's focus on the patients' perspectives by Wang, Yiman, Snoep, Jaapjan D, Hemmelder, Marc H, van der Bogt, Koen E A, Bos, Willem Jan W, van der Boog, Paul J M, Dekker, Friedo W, de Vries, Aiko P J, Meuleman, Yvette

    Published in Clinical kidney journal (01-06-2021)
    “…Graft function and patient survival are traditionally the most used parameters to assess the objective benefits of kidney transplantation. Monitoring graft…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Renal transplant patient acceptance of a self-management support system by Wang, Wenxin, van Lint, Céline L, Brinkman, Willem-Paul, Rövekamp, Ton J M, van Dijk, Sandra, van der Boog, Paul J M, Neerincx, Mark A

    “…Self-management support systems (SMSS) have been proposed for renal transplant patients to increase their autonomy and reduce the number of hospital visits…”
    Get full text
    Journal Article
  12. 12

    Pretransplantation GAD-Autoantibody Status to Guide Prophylactic Antibody Induction Therapy in Simultaneous Pancreas and Kidney Transplantation by Ringers, Jan, van der Torren, Cornelis R, van de Linde, Pieter, van der Boog, Paul J.M, Mallat, Marko J.K, Bonifacio, Ezio, Roep, Bart O, de Fijter, Johan W

    Published in Transplantation (27-10-2013)
    “…BACKGROUNDDaclizumab and antithymocyte globulin (ATG) have been shown to reduce allograft rejection. We assessed the safety and efficacy of daclizumab or ATG…”
    Get full text
    Journal Article
  13. 13

    Patients’ and healthcare professionals’ beliefs, perceptions and needs towards chronic kidney disease self-management in China: a qualitative study by Shen, Hongxia, van der Kleij, Rianne M J J, van der Boog, Paul J M, Wang, Wenjiao, Song, Xiaoyue, Li, Zhengyan, Lou, Xiaoping, Chavannes, Niels

    Published in BMJ open (04-03-2021)
    “…ObjectivesTo support the adaptation and translation of an evidence-based chronic kidney disease (CKD) self-management intervention to the Chinese context, we…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Psychological Distress and Self-Management in CKD: A Cross-Sectional Study by Cardol, Cinderella K., Meuleman, Yvette, van Middendorp, Henriët, van der Boog, Paul J.M., Hilbrands, Luuk B., Navis, Gerjan, Sijpkens, Yvo W.J., Sont, Jacob K., Evers, Andrea W.M., van Dijk, Sandra

    Published in Kidney medicine (01-10-2023)
    “…Patients with chronic kidney disease (CKD) not receiving dialysis, including kidney transplant recipients, often experience difficulties regarding…”
    Get full text
    Journal Article
  16. 16

    Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study by Veltkamp, Denise M J, Wang, Yiman, Meuleman, Yvette, Dekker, Friedo W, Michels, Wieneke M, van der Boog, Paul J M, de Vries, Aiko P J

    Published in Nephrology, dialysis, transplantation (30-06-2023)
    “…ABSTRACT Background Health-related quality of life (HRQOL) is an increasingly important patient-reported outcome in kidney transplant recipients (KTRs). This…”
    Get full text
    Journal Article
  17. 17

    Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients by Zwart, Tom C., Metscher, Erik, Boog, Paul J. M., Swen, Jesse J., Fijter, Johan W., Guchelaar, Henk‐Jan, Vries, Aiko P. J., Moes, Dirk Jan A. R.

    Published in British journal of clinical pharmacology (01-11-2022)
    “…Aims Immunosuppressant and kidney function monitoring are crucial for kidney transplant recipient follow‐up. Microsamples enable remote sampling and minimise…”
    Get full text
    Journal Article
  18. 18

    Tacrolimus and Mycophenolic Acid Exposure Are Associated with Biopsy‐Proven Acute Rejection: A Study to Provide Evidence for Longer‐Term Target Ranges by Meziyerh, Soufian, Gelder, Teun, Kers, Jesper, Helm, Danny, Boog, Paul J. M., Fijter, Johan W., Moes, Dirk Jan A. R., Vries, Aiko P. J.

    Published in Clinical pharmacology and therapeutics (01-07-2023)
    “…Evidence to define target ranges for tacrolimus (Tac) and mycophenolic acid (MPA) exposure after the first year of kidney transplantation is limited. We…”
    Get full text
    Journal Article
  19. 19

    Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation by Zwart, Tom C., Guchelaar, Henk-Jan, van der Boog, Paul J.M., Swen, Jesse J., van Gelder, Teun, de Fijter, Johan W., Moes, Dirk Jan A.R.

    Published in Drug discovery today (01-11-2021)
    “…•Immunosuppression is key for sustained graft survival after renal transplantation.•Optimally balanced immunosuppressive therapy is challenged by PK…”
    Get full text
    Journal Article
  20. 20